Insulin glulisine and Ranibizumab ophthalmic
Determining the interaction of Insulin glulisine and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin Glulisine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine-Ranitidine
- Insulin glulisine-Ranitidine Capsule
- Insulin glulisine-Ranitidine Hydrochloride
- Insulin glulisine-Ranitidine Injection
- Insulin glulisine-Ranitidine Suspension
- Insulin glulisine-Ranitidine Syrup
- Ranibizumab ophthalmic-Insulin Glulisine (Cartridges and Pens)
- Ranibizumab ophthalmic-Insulin Glulisine (Vials)
- Ranibizumab ophthalmic-Insulin glulisine Subcutaneous
- Ranibizumab ophthalmic-Insulin human inhaled Inhalation
- Ranibizumab ophthalmic-Insulin human regular Injection
- Ranibizumab ophthalmic-Insulin inhalation